Redmile Group, LLC Puma Biotechnology, Inc. Transaction History

Redmile Group, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 14, 2018	SELL	$48.3 - $68.25 $52.9 Million - $74.8 Million	-1,095,612 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$59.7 - $99.25 $10.9 Million - $18.1 Million	182,039 Added 19.93%	1,095,612 $0
Q4 2017 Feb 14, 2018	BUY	$93.85 - $132.45 $650,474 - $918,010	6,931 Added 0.76%	913,573 $90.3 Million
Q3 2017 Nov 14, 2017	BUY	$72.0 - $119.75 $65.3 Million - $109 Million	906,642	906,642 $109 Million

109

28.3M

17.9K

3.4K

Ticker PBYI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,556,000
Market Cap $133M
Description
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...

Get notified when there are updates to the investment portfolio of Redmile Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Redmile Group, LLC with notifications on news.